Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers

Mostrar otras versiones (1)

Oral fluid (hereafter saliva) offers a non-invasive sampling method for the detection of SARS-CoV-2 antibodies. However, data comparing performance of salivary tests against commercially-available serologic and neutralizing antibody (nAb) assays are lacking. This study compared the performance of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Heaney, Christopher D., Pisanic, Nora, Randad, Pranay R., Kruczynski, Kate, Howard, Tyrone, Zhu, Xianming, Littlefield, Kirsten, Patel, Eshan U., Shrestha, Ruchee, Laeyendecker, Oliver, Shoham, Shmuel, Sullivan, David, Gebo, Kelly, Hanley, Daniel, Redd, Andrew D., Quinn, Thomas C., Casadevall, Arturo, Zenilman, Jonathan M., Pekosz, Andrew, Bloch, Evan M., Tobian, Aaron A. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852272/
https://www.ncbi.nlm.nih.gov/pubmed/33532806
http://dx.doi.org/10.1101/2021.01.28.21250717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852272/
https://www.ncbi.nlm.nih.gov/pubmed/33532806
http://dx.doi.org/10.1101/2021.01.28.21250717

Ejemplares similares